1.15. Analysis.
Comparison 1: Higher‐dose anticoagulants versus lower‐dose anticoagulants (short term), Outcome 15: Adverse events (major adverse limb event)
Comparison 1: Higher‐dose anticoagulants versus lower‐dose anticoagulants (short term), Outcome 15: Adverse events (major adverse limb event)